Notice Title

Consent to the Distribution of a New Medicine

Publication Date
2 Nov 2023

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2023-go5103
Title
View PDF
File Type and Size
PDF (33 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Lamictal
Active Ingredient: Lamotrigine 2mg
Dosage Form: Chewable/dispersible tablet
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturer: GlaxoSmithKline LLC, North Carolina, United States of America


Dated this 30th day of October 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).